Vasilena Sitnilska, Ulrike Brocks, Jan Tode, Georg Spital, Lebriz Altay
{"title":"[中枢性浆液性脉络膜视网膜病变治疗的比较-微脉冲激光与光动力治疗]。","authors":"Vasilena Sitnilska, Ulrike Brocks, Jan Tode, Georg Spital, Lebriz Altay","doi":"10.1007/s00347-025-02183-0","DOIUrl":null,"url":null,"abstract":"<p><p>The therapeutic management of central serous chorioretinopathy (CSC) remains challenging. Although CSC shows a high rate of self-resorption, frequent recurrences or chronification of the disease can result in irreversible loss of vision. Low-dose photodynamic therapy (half-dose or half-fluence PDT) represents the current standard of care for CSC, although regenerative laser procedures may also offer a safe and effective alternative for the treatment of CSC.</p>","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"186-195"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Treatment of central serous chorioretinopathy in comparison-Micropulse laser versus photodynamic therapy].\",\"authors\":\"Vasilena Sitnilska, Ulrike Brocks, Jan Tode, Georg Spital, Lebriz Altay\",\"doi\":\"10.1007/s00347-025-02183-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The therapeutic management of central serous chorioretinopathy (CSC) remains challenging. Although CSC shows a high rate of self-resorption, frequent recurrences or chronification of the disease can result in irreversible loss of vision. Low-dose photodynamic therapy (half-dose or half-fluence PDT) represents the current standard of care for CSC, although regenerative laser procedures may also offer a safe and effective alternative for the treatment of CSC.</p>\",\"PeriodicalId\":72808,\"journal\":{\"name\":\"Die Ophthalmologie\",\"volume\":\" \",\"pages\":\"186-195\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Die Ophthalmologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s00347-025-02183-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Die Ophthalmologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00347-025-02183-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/7 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
[Treatment of central serous chorioretinopathy in comparison-Micropulse laser versus photodynamic therapy].
The therapeutic management of central serous chorioretinopathy (CSC) remains challenging. Although CSC shows a high rate of self-resorption, frequent recurrences or chronification of the disease can result in irreversible loss of vision. Low-dose photodynamic therapy (half-dose or half-fluence PDT) represents the current standard of care for CSC, although regenerative laser procedures may also offer a safe and effective alternative for the treatment of CSC.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
